Rua Bioscience Limited (RUA.NZ)
NZSE · NZD · Healthcare · Drug Manufacturers - Specialty & Generic
NZ$0.026 (+0.00%) as of
Key statistics
- Market cap
- 9.86M
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0250 – 0.0420
- Beta
- 0.58
- Revenue (TTM)
- 2.81M
- Profit margin
- -119.53%
- Volume
- 73.73k
About Rua Bioscience Limited
Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in plant research, genetic discovery, seed production, and breeding development related activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is based in Ruatoria, New Zealand.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Ruatoria, New Zealand
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- RUA Gold Inc Ordinary Shares (RGI.NZ)
- ikeGPS Group Limited Ordinary S (IKE.NZ)
- Chatham Rock Phosphate Limited (CRP.NZ)
- TruScreen Group Limited Ordinar (TRU.NZ)
- New Talisman Gold Mines Limited (NTL.NZ)
- AoFrio Limited Ordinary Shares (AOF.NZ)
- PaySauce Limited Ordinary Share (PYS.NZ)
- Black Pearl Group Limited Ordin (BPG.NZ)